Beyond Air (XAIR) Convertible Debt (2015 - 2016)
Beyond Air (XAIR) reported Convertible Debt of $2.9 million for Q4 2016, up 86.53% on a YoY basis from $1.6 million in Q1 2016, and up 86.53% sequentially from $1.6 million in Q4 2015.
Beyond Air (XAIR) Convertible Debt (2015 - 2016) Analysis & Trends
Beyond Air (XAIR) has 2 years of Convertible Debt data on file, last reported at $2.9 million in Q4 2016.
- For the quarter ending Q4 2016, Convertible Debt rose 86.53% year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2016 stood at $2.9 million (up 86.53% YoY), and the FY2016 full-year result was $2.9 million, up 86.53% from the prior year.
- Convertible Debt grew to $2.9 million in Q4 2016, from $1.6 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $2.9 million in Q4 2016 to a low of $1.6 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Beyond Air | 2.25 Mn | -10.02 Mn | 94,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.90 Mn |
| Dec 31, 2015 | 1.55 Mn |